PRP Inc. announced that the U.S. Patent and Trademark Officehas awarded it a broad-based patent, No. 5,185,160, covering avirus-free, freeze-dried platelet derivitive and its use intransfusion to control bleeding.
The Watertown, Mass., company said that the patent alsocovers the methods for producing the platelet derivitive fromfresh or outdated platelets.
(c) 1997 American Health Consultants. All rights reserved.